Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-02 · accession 0001415889-24-024676 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-03 | 2024-10-03 | WHWK | Lennon David James | CEO, Dir | S - Sale+OE | $1.94 | -9,689 | 22.9K | -30% | -$18.8K |
| D | 2024-10-03 | 2024-10-02 | WHWK | Lennon David James | CEO, Dir | M - OptEx | $0.00 | +32.6K | 32.6K | New | $0 |
| D | 2024-10-03 | 2024-10-02 | WHWK | Lennon David James | CEO, Dir | M - OptEx | $0.00 | -32.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-03 | S | D | 9,689 | $1.94 | 22,869 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-02 | M | A | 32,558 | $0.00 | 32,558 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. |
| 3 | Derivative | Restricted Stock Units | 2024-10-02 | M | D | 32,558 | $0.00 | 0 | D | — · — to — | 32,558 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. (F3) One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024. |